Albert Garcia-Romeu

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Venues

Journal of psychopharmacology (Oxford, England)

The American journal of drug and alcohol abuse

Addiction (Abingdon, England)

Current topics in behavioral neurosciences

Johns Hopkins Medicine

Institute of Transpersonal Psychology (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Johns Hopkins Medicine Jul 15o 2015

United States

Research Associate :: Psychiatry & Behavioral Sciences

Education History

Institute of Transpersonal Psychology Sep 1o 2007 - May 28o 2012

United States

PHD

Publications

Suky Martinez, Albert Garcia-Romeu, Freymon Perez, Jermaine D Jones
Resilience Phenotypes and Psychological Functioning among Individuals with Opioid Use Disorder. Substance use & misuse (2023)
Justin N Bonnieux, Baeleigh VanderZwaag, Zahra A Premji, Albert Garcia-Romeu, Mauricio A Garcia-Barrera
Psilocybin's effects on cognition and creativity: A scoping review. Journal of psychopharmacology (Oxford, England) (2023)
Oliver Grundmann, Albert Garcia-Romeu, Christopher R McCurdy, Abhisheak Sharma, Kirsten E Smith, Marc T Swogger, Stephanie T Weiss
Not all kratom is equal: The important distinction between native leaf and extract products. Addiction (Abingdon, England) (2023)
Kirsten Elin Smith, Kelly E Dunn, Jeffrey M Rogers, Oliver Grundmann, Christopher R McCurdy, Albert Garcia-Romeu, Destiny Schriefer, Marc T Swogger, David H Epstein
Kratom use as more than a "self-treatment". The American journal of drug and alcohol abuse 48 (6) (2022)
Kirsten Elin Smith, Kelly E Dunn, David H Epstein, Jeffrey D Feldman, Albert Garcia-Romeu, Oliver Grundmann, Jack E Henningfield, Christopher R McCurdy, Jeffrey M Rogers, Destiny Schriefer, Darshan Singh, Stephanie T Weiss
Need for clarity and context in case reports on kratom use, assessment, and intervention. Substance abuse 43 (1) (2022)
Albert Garcia-Romeu, Sean Darcy, Hillary Jackson, Toni White, Paul Rosenberg
Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms. Current topics in behavioral neurosciences (2021)
Kirsten Elin Smith, Kelly E Dunn, Oliver Grundmann, Albert Garcia-Romeu, Jeffrey M Rogers, Marc T Swogger, David H Epstein
Social, psychological, and substance use characteristics of U.S. adults who use kratom: Initial findings from an online, crowdsourced study. Experimental and clinical psychopharmacology (2021)
David J Cox, Albert Garcia-Romeu, Matthew W Johnson
Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narratives. The American journal of drug and alcohol abuse 47 (4) (2021)
Albert Garcia-Romeu, Frederick S Barrett, Theresa M Carbonaro, Matthew W Johnson, Roland R Griffiths
Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches. Journal of psychopharmacology (Oxford, England) 35 (4) (2021)
Oliver Grundmann, Jane K Babin, Jack E Henningfield, Albert Garcia-Romeu, Andrew C Kruegel, Walter C Prozialeck, Robert B Raffa, Darshan Singh, Kirsten E Smith
Kratom use in the United States: a diverse and complex profile. Addiction (Abingdon, England) 116 (1) (2020)
Albert Garcia-Romeu, Alan K Davis, Fire Erowid, Earth Erowid, Roland R Griffiths, Matthew W Johnson
Cessation and reduction in alcohol consumption and misuse after psychedelic use. Journal of psychopharmacology (Oxford, England) 33 (9) (2019)

Albert Garcia-Romeu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Albert Garcia-Romeu